"Designing Growth Strategies is in our DNA"

Macrolide Antibiotics Market Size, Share & Industry Analysis, By Product (Azithromycin, Clarithromycin, Oleandomycin, Erythromycin, and Others), By Disease Indication (Respiratory Infections, Skin Infections, Sexually Transmitted Diseases (STIs), and Others), By Route of Administration (Oral, Parenteral, and Others), By Age Group (Adults and Pediatrics), By Distribution Channel (Hospital Pharmacies, Drug Stores & Retail Pharmacies, and Online Pharmacies), and Regional Forecasts, 2025-2032

Last Updated: November 17, 2025 | Format: PDF | Report ID: FBI113847

 


To get information on various segments, share your queries with us

ATTRIBUTE

DETAILS

Study Period

2019-2032

Base Year

2024

Estimated Year 

2025

Forecast Period

2025-2032

Historical Period

2019-2023

Growth Rate

CAGR of 3.9% from 2025-2032

Unit

Value (USD Billion)

Segmentation

By  Product

  • Azithromycin
  • Clarithromycin
  • Oleandomycin
  • Erythromycin
  • Others

By Disease Indication

  • Respiratory Infections
  • Skin Infections
  • Sexually Transmitted Diseases (STIs)
  • Others

By Route of Administration

  • Oral
  • Parenteral
  • Others

By Age Group

  • Adults
  • Pediatrics

By Distribution Channel

  • Hospital Pharmacies
  • Drug Stores & Retail Pharmacies
  • Online Pharmacies

By Region

  • North America (By Product, Disease Indication, Route of Administration, Age Group, Distribution Channel, and Country)
    • U.S.
    • Canada
  • Europe (By Product, Disease Indication, Route of Administration, Age Group, Distribution Channel, and Country/sub-region)
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Scandinavia
    • Rest of Europe
  • Asia Pacific (By Product, Disease Indication, Route of Administration, Age Group, Distribution Channel, and Country/sub-region)
    • China
    • Japan
    • India
    • Australia
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America (By Product, Disease Indication, Route of Administration, Age Group, Distribution Channel, and Country/sub-region)
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa (By Product, Disease Indication, Route of Administration, Age Group, Distribution Channel, and Country/sub-region)
    • GCC
    • South Africa
    • Rest of the Middle East & Africa

 

  • 2019-2032
  • 2024
  • 2019-2023
  • 159
Download Free Sample

    man icon
    Mail icon
Growth Advisory Services
    How can we help you uncover new opportunities and scale faster?
Clients
3M
Toshiba
Fresenius
Johnson
Siemens
Abbot
Allergan
American Medical Association
Becton, Dickinson and Company
Bristol-Myers Squibb Company
Henry Schein
Mckesson
Mindray
National Institutes of Health (NIH)
Nihon Kohden
Olympus
Quest Diagnostics
Sanofi
Smith & Nephew
Straumann